| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 09/12/2002 | WO2001012600A9 INHIBITORS OF FACTOR Xa |
| 09/12/2002 | US20020128510 Antiarthritic agents; rheumatic diseases; osteoarthritis; inhibition of the inducible nitric oxide synthase - induced after activation of vascular smooth muscle, macrophages, endothelial cells by enotoxin and cytokines |
| 09/12/2002 | US20020128290 Derivatives of benzofuran or benzodioxole |
| 09/12/2002 | US20020128272 4,5,6, and 7-indole and indoline derivatives, their preparation and use |
| 09/12/2002 | US20020128270 Treating stroke, arhtritis, cancer, tissue ulceration, decubitis ulcer, restenosis, periodontal disease, epidermolysis bullosa, scleritis, psoriasis, AIDS, sepsis, and septic shock. |
| 09/12/2002 | US20020128266 ABCA-1 elevating compounds |
| 09/12/2002 | US20020128263 Treatment or prevention of mGluR5 receptor mediated disorders. |
| 09/12/2002 | US20020128262 Styrylbenzodiazepines |
| 09/12/2002 | US20020128247 Phenyl sulfamide derivatives as dietetics, antidiabetics, and hypotensive agents |
| 09/12/2002 | US20020128185 Cryptophycin compounds useful for disrupting the microtubulin system; antineoplastic, antifungal, and anticancer agents |
| 09/12/2002 | CA2439827A1 Peptide deformylase inhibitors |
| 09/12/2002 | CA2439666A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| 09/12/2002 | CA2439644A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 09/12/2002 | CA2437840A1 Heterocyclic diamide invertebrate pest control agents |
| 09/12/2002 | CA2437594A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/12/2002 | CA2433467A1 Substituted quinolinecarboxamides as antiviral agents |
| 09/12/2002 | CA2431549A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 09/11/2002 | EP1238975A1 Difluoromethyltriazolone compounds, use of the same and intermediates for the production thereof |
| 09/11/2002 | EP1238974A1 Heterocycle derivatives and drugs |
| 09/11/2002 | EP1238970A1 Cycloamine ccr5 receptor antagonists |
| 09/11/2002 | EP1237953A2 Polymerization of olefins |
| 09/11/2002 | EP1237895A2 Phosphorylation of terminal primary alcohol groups |
| 09/11/2002 | EP1237889A1 Antibiotic sultam and sultone derived oxazolidinones |
| 09/11/2002 | EP1237888A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 09/11/2002 | EP1237887A1 9-(piperazinylalkyl)carbazoles as bax-modulators |
| 09/11/2002 | EP1237875A1 Substituted imidazole neuropeptide y y5 receptor antagonists |
| 09/11/2002 | EP1237874A2 Selective neurokinin antagonists |
| 09/11/2002 | EP1237869A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 09/11/2002 | EP1237868A1 Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors |
| 09/11/2002 | EP1237867A1 Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors |
| 09/11/2002 | EP1237862A1 Succinate compounds, compositions and methods of use and preparation |
| 09/11/2002 | EP1237551A1 Pharmaceutical formulations containing zolmitriptan |
| 09/11/2002 | EP0934309B1 New pyridyl alkane acid amides as cytostatics and immunosuppressives |
| 09/11/2002 | EP0799206B1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 09/11/2002 | EP0668860B1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses |
| 09/11/2002 | CN1368972A Nonsteroid IL-5 inhibitor, its preparation method and medical composition containing the inhibitor |
| 09/11/2002 | CN1368961A Compounds for modulation of PPAP gamma activity |
| 09/11/2002 | CN1090631C Heterocyclic compounds, preparation process thereof and medicinal composition containing same |
| 09/11/2002 | CN1090629C Novel Heterocyclic compounds |
| 09/11/2002 | CN1090627C 2-amino-1,2-indene compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/11/2002 | CN1090625C Method for selective protection of baccation derivatives and its application to taxane synthesis |
| 09/11/2002 | CN1090623C 3-aryl-1,2,4-triazole derivatives with herbicidal properties |
| 09/10/2002 | US6448405 Coupling a 2-halo-5-nitrobenzoic acid and a 2-methoxyphenyl boronic acid; cyclizing to a nitrobenzocoumarin; reducing to the amine; converting to a coumarino(3,4-f)quinoline; reduction to a 5h-chromeno(3,4-f)quinoline |
| 09/10/2002 | US6448396 Compounds useful as neuro-protective agents |
| 09/10/2002 | US6448281 Inhibitors of hepatitis c virus replication; treatment of hepatitis c |
| 09/10/2002 | US6448277 VEGF receptor tyrosine kinase inhibitors |
| 09/10/2002 | US6448276 Such as 1-pyridin-3-yl-4-pyrrolidin-1-yl-but-1-ene; increasing hydration and lubrication of vaginal and cervical tissues; nicotine, epibatidine alkaloids and analogs |
| 09/10/2002 | US6448270 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists |
| 09/10/2002 | US6448250 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 09/10/2002 | US6448247 Tachykinin receptor antagonist; especially to the receptors for substance p (which receptors are generally referred to as ?neurokinin 1 receptors?) |
| 09/10/2002 | US6448244 Broad-spectrum antifungals, against which there is no existing resistance and which can be administered intravenously or transungually |
| 09/10/2002 | US6448203 Substituted aryluracils |
| 09/10/2002 | US6448201 Benzoylcyclohexanediones and benzoylpyrazoles, their preparation, and their use as herbicides and plant growth regulators |
| 09/10/2002 | CA2240946C Isoxazoline, isothiazoline and pyrazoline factor xa inhibitors |
| 09/10/2002 | CA2195129C Substituted piperidine intermediates for producing heterocyclic-cyclic amine derivatives capable of inhibiting cholinesterase |
| 09/06/2002 | WO2002068417A2 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 09/06/2002 | WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2002 | WO2002068409A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 09/06/2002 | WO2002068406A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 09/06/2002 | WO2002068393A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 09/06/2002 | WO2002068388A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | WO2002068387A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | WO2002067939A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/06/2002 | WO2002067869A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | WO2002067865A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 09/06/2002 | WO2002067684A1 Pyridyl pyrimidines for use as pesticides |
| 09/06/2002 | WO2002022577A3 Hydroxamate derivatives useful as deacetylase inhibitors |
| 09/06/2002 | WO2002012534A3 Bio-intermediates for use in the chemical synthesis of polyketides |
| 09/06/2002 | WO2002008475A3 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 09/06/2002 | CA2439265A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/06/2002 | CA2439119A1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | CA2438895A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 09/06/2002 | CA2434666A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 09/05/2002 | US20020123629 Benzothiadiazoles and derivatives |
| 09/05/2002 | US20020123513 Administering indole-2-carboxylic amide derivatives of given formula |
| 09/05/2002 | US20020123502 5-(4-(2-(2,4-dimethyl-6-oxo-1,6-dihydro-1-pyrimidinyl) -ethoxy)phenyl methyl)thiazolidine-2,4-dione for example; also oxazolidine-2,4-dione, and 1,2,4-oxadiazolidine-3,5-dione derivatives; reducing blood glucose levels |
| 09/05/2002 | US20020123491 Selective neurokinin antagonists |
| 09/05/2002 | DE10110325A1 Phenylderivate 2 Phenyl derivatives 2 |
| 09/05/2002 | DE10109867A1 Verwendung von Triazolverbindungen zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie Use of triazole compounds for the prophylaxis and treatment of neurodegenerative diseases, brain trauma and cerebral ischemia |
| 09/04/2002 | EP1236723A1 Sulfamide derivatives useful as beta3 agonists and pharmaceutical uses thereof |
| 09/04/2002 | EP1236719A1 Novel heterocyclic compounds and salts thereof and medicinal use of the same |
| 09/04/2002 | EP1235825A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 09/04/2002 | EP1235816A1 Benzoylcyclohexandione and benzoylpyrazols, method for the production and use thereof as herbicides and plant growth regulators |
| 09/04/2002 | EP1235803A1 Urea compounds having muscarinic receptor antagonist activity |
| 09/04/2002 | EP1235802A1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 09/04/2002 | EP1054886B1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors |
| 09/04/2002 | EP0944672B1 Helium-neon excitable reticulocyte dyes derivable from halolepidines |
| 09/04/2002 | EP0882043B1 Halogen pyrimidines and its use thereof as parasite abatement means |
| 09/04/2002 | EP0809636B1 Substituted isoxazoles for the treatment of inflammation |
| 09/04/2002 | EP0642506B1 Heterocyclically bisubstituted sulphonyl amino(thio)carbonyl compounds |
| 09/04/2002 | CN1367780A Oxazolidinones and their preparing method and use thereof |
| 09/04/2002 | CN1090020C 4,4-(disubstituted) cyclohexan-1-ols and related compounds |
| 09/04/2002 | CN1090019C 组合物 The composition |
| 09/03/2002 | US6444827 From beta-methyl l-aspartate via chemical intermediate; efficiency; antidiabetic agents |
| 09/03/2002 | US6444823 Pyridyl alkane acid amides as cytostatics and immunosuppressives |
| 09/03/2002 | US6444811 Central nervous system disorders; cardiovascular disorders |
| 09/03/2002 | US6444809 Antihistamines |
| 09/03/2002 | US6444687 Eating disorders and diabetes |
| 09/03/2002 | US6444686 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 09/03/2002 | US6444679 Neurological and gastrointestinal disorders; delta opioid ligands or opioid receptors |